|
DE3584341D1
(de)
|
1984-08-24 |
1991-11-14 |
Upjohn Co |
Rekombinante dna-verbindungen und expression von polypeptiden wie tpa.
|
|
US5168062A
(en)
|
1985-01-30 |
1992-12-01 |
University Of Iowa Research Foundation |
Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
|
|
US4797368A
(en)
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
|
US5436146A
(en)
|
1989-09-07 |
1995-07-25 |
The Trustees Of Princeton University |
Helper-free stocks of recombinant adeno-associated virus vectors
|
|
US6268213B1
(en)
|
1992-06-03 |
2001-07-31 |
Richard Jude Samulski |
Adeno-associated virus vector and cis-acting regulatory and promoter elements capable of expressing at least one gene and method of using same for gene therapy
|
|
US5869305A
(en)
|
1992-12-04 |
1999-02-09 |
The University Of Pittsburgh |
Recombinant viral vector system
|
|
US5478745A
(en)
|
1992-12-04 |
1995-12-26 |
University Of Pittsburgh |
Recombinant viral vector system
|
|
US6204059B1
(en)
|
1994-06-30 |
2001-03-20 |
University Of Pittsburgh |
AAV capsid vehicles for molecular transfer
|
|
US5741683A
(en)
|
1995-06-07 |
1998-04-21 |
The Research Foundation Of State University Of New York |
In vitro packaging of adeno-associated virus DNA
|
|
US6093570A
(en)
|
1995-06-07 |
2000-07-25 |
The University Of North Carolina At Chapel Hill |
Helper virus-free AAV production
|
|
US6001650A
(en)
|
1995-08-03 |
1999-12-14 |
Avigen, Inc. |
High-efficiency wild-type-free AAV helper functions
|
|
JP2001500015A
(ja)
|
1996-09-06 |
2001-01-09 |
トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
Ｔ７ポリメラーゼを利用する組換えアデノ随伴ウイルスの誘導可能な製造方法
|
|
AU728220B2
(en)
|
1997-04-14 |
2001-01-04 |
Cell Genesys, Inc. |
Methods for increasing the efficiency of recombinant AAV product
|
|
US6156303A
(en)
|
1997-06-11 |
2000-12-05 |
University Of Washington |
Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
|
|
EP1080218A1
(en)
|
1998-05-27 |
2001-03-07 |
University of Florida |
Method of preparing recombinant adeno-associated virus compositions by using an iodixanol gradient
|
|
ATE454445T1
(de)
|
1998-11-10 |
2010-01-15 |
Univ North Carolina |
Virusvektoren und verfahren für ihre herstellung und verabreichung.
|
|
CA2410901C
(en)
|
2000-06-01 |
2012-03-20 |
University Of North Carolina At Chapel Hill |
Methods and compounds for controlled release of recombinant parvovirus vectors
|
|
AU2002303330B2
(en)
|
2001-05-31 |
2008-07-24 |
Novartis Vaccines And Diagnostics, Inc. |
Chimeric alphavirus replicon particles
|
|
US7045335B2
(en)
|
2001-09-06 |
2006-05-16 |
Alphavax, Inc. |
Alphavirus replicon vector systems
|
|
SG10202108118RA
(en)
|
2001-11-13 |
2021-08-30 |
Univ Pennsylvania |
A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
|
|
ES2975413T3
(es)
|
2001-12-17 |
2024-07-05 |
Univ Pennsylvania |
Secuencias de serotipo 8 de virus adenoasociado (AAV), vectores que las contienen y usos de las mismas
|
|
US20070015238A1
(en)
|
2002-06-05 |
2007-01-18 |
Snyder Richard O |
Production of pseudotyped recombinant AAV virions
|
|
HUE054805T2
(hu)
|
2003-09-30 |
2021-09-28 |
Univ Pennsylvania |
Adeno-asszociált vírus (AAV) kládok, szekvenciák, az azokat tartalmazó vektorok és alkalmazásaik
|
|
WO2005073384A2
(en)
|
2004-01-28 |
2005-08-11 |
Research Development Foundation |
Human soluble neuropilin-1 primary polyadenylation signal and uses thereof
|
|
WO2006012414A2
(en)
|
2004-07-20 |
2006-02-02 |
Critical Therapeutics, Inc. |
Novel polyadenylation signal for use in expression vectors
|
|
EP3085389A1
(en)
|
2005-04-07 |
2016-10-26 |
The Trustees Of The University Of Pennsylvania |
Method of increasing the function of an aav vector
|
|
WO2007120542A2
(en)
|
2006-03-30 |
2007-10-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Aav capsid library and aav capsid proteins
|
|
EP3663395B1
(en)
|
2012-03-26 |
2024-07-31 |
The United States of America, as Represented by The Secretary, Department of Health and Human Services Office of Technology, Transfer, |
Delivery of packaged rna to mammalian cells
|
|
GB201518979D0
(en)
|
2015-10-27 |
2015-12-09 |
Univ Leuven Kath |
Treatment of hepatic steatosis related oligo-ovulation
|
|
US10201455B2
(en)
|
2016-06-22 |
2019-02-12 |
The Charles Stark Draper Laboratory, Inc. |
System for inner ear drug delivery via trans-round window membrane injection
|
|
EP3510161A4
(en)
|
2016-08-23 |
2020-04-22 |
Akouos, Inc. |
COMPOSITIONS AND METHODS FOR TREATING PERSONAL HEARING LOSS IN A PERSON
|
|
US11439749B2
(en)
|
2017-10-25 |
2022-09-13 |
The Charles Stark Draper Laboratory, Inc. |
Apparatus and method for trans-round window membrane drug delivery
|
|
IL276764B2
(en)
|
2018-02-22 |
2026-05-01 |
Akouos Inc |
Compositions and methods for treating non-age-related hearing impairment in humans
|
|
WO2019200016A1
(en)
*
|
2018-04-10 |
2019-10-17 |
President And Fellows Of Harvard College |
Aav vectors encoding clarin-1 or gjb2 and uses thereof
|
|
EP3824090A4
(en)
*
|
2018-06-25 |
2022-06-01 |
Akouos, Inc. |
METHODS OF TREATING HEARING LOSS AND/OR LOSS OF VISION ASSOCIATED WITH CLRN1
|
|
EP4063510A1
(en)
|
2018-11-07 |
2022-09-28 |
Akouos, Inc. |
Use of adeno-associated viral vectors to correct gene defects/ express proteins in hair cells and supporting cells in the inner ear
|
|
JP2023527366A
(ja)
|
2020-05-27 |
2023-06-28 |
アコーオス インコーポレイテッド |
流体を内耳に送達するためのデバイス、システム、及び方法
|